Project Details
| Status | Active |
|---|---|
| Effective start/end date | 20/08/24 → 19/08/29 |
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Multicenter, Randomized, Open-Label Trial of Epcoritamab plus Lenalidomide compared to Rituximab plus Gemcitabine and Oxaliplatin in Participants with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Opat, Stephen (Primary Chief Investigator (PCI))
- Gregory, Gareth (Chief Investigator (CI))
Project: Research